{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:31:20Z","timestamp":1783031480436,"version":"3.54.6"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jaip.2017.12.020","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T10:29:19Z","timestamp":1518517759000},"page":"1553-1558.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Patients Taking \u03b2-Blockers Do Not Require Increased Doses of Epinephrine for Anaphylaxis"],"prefix":"10.1016","volume":"6","author":[{"given":"Jennifer L.","family":"White","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie C.","family":"Greger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangil","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Kahoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Lohse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronna L.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2017.12.020_bib1","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jaci.2014.05.018","article-title":"Risk factors for severe anaphylaxis in patients receiving anaphylaxis treatment in US emergency departments and hospitals","volume":"134","author":"Clark","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.12.020_bib2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0091-6749(73)90091-2","article-title":"Effect of beta adrenergic stimulation and blockade on immediate hypersensitivity skin test reactions","volume":"52","author":"Shereff","year":"1973","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.12.020_bib3","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaci.2013.01.011","article-title":"Antihypertensive medication use is associated with increased organ system involvement and hospitalization in emergency department patients with anaphylaxis","volume":"131","author":"Lee","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.12.020_bib4","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaci.2014.09.004","article-title":"Ramipril and metoprolol intake aggravate human and murine anaphylaxis: evidence for direct mast cell priming","volume":"135","author":"Nassiri","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.12.020_bib5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0091-6749(76)90119-6","article-title":"Hypersensitivity to histamine and systemic anaphylaxis in mice with pharmacologic beta adrenergic blockade: protection by nucleotides","volume":"58","author":"Matsumura","year":"1976","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.12.020_bib6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/ACI.0b013e328259c328","article-title":"Cardiovascular disease and anaphylaxis","volume":"7","author":"Mueller","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.12.020_bib7","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1001\/archinte.1993.00410170119012","article-title":"Elevated risk of anaphylactoid reaction from radiographic contrast media is associated with both beta-blocker exposure and cardiovascular disorders","volume":"153","author":"Lang","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaip.2017.12.020_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.zefq.2016.07.010","article-title":"The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement [in German]","volume":"115-116","author":"Benchimol","year":"2016","journal-title":"Z\u00a0Evid Fortbild Qual Gesundhwes"},{"key":"10.1016\/j.jaip.2017.12.020_bib9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2005.12.1303","article-title":"Second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium. Second symposium on the definition and management of anaphylaxis: summary report","volume":"117","author":"Sampson","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.12.020_bib10","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jaip.2015.04.009","article-title":"Predictors of repeat epinephrine administration for emergency department patients with anaphylaxis","volume":"3","author":"Campbell","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2017.12.020_bib11","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/cpt1971123559","article-title":"Propranolol [correspondence]","volume":"12","author":"Corbascio","year":"1971","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2017.12.020_bib12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2165\/00002018-199512050-00002","article-title":"Anaphylactoid and anaphylactic reactions: hazards of beta-blockers","volume":"12","author":"Lang","year":"1995","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaip.2017.12.020_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0091-6749(88)90212-6","article-title":"Risk of anaphylaxis in patients receiving beta-blocker drugs","volume":"81","author":"Toogood","year":"1988","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.12.020_bib14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaci.2004.04.029","article-title":"Clinical features and severity grading of anaphylaxis","volume":"114","author":"Brown","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.12.020_bib15","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/00000542-199009000-00004","article-title":"Test doses: optimal epinephrine content with and without acute beta-adrenergic blockade","volume":"73","author":"Guinard","year":"1990","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jaip.2017.12.020_bib16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF01619262","article-title":"Epinephrine-containing test dose during beta-blockade","volume":"7","author":"Mackie","year":"1991","journal-title":"J\u00a0Clin Monit"},{"key":"10.1016\/j.jaip.2017.12.020_bib17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-0773.1975.tb03322.x","article-title":"Influence of metoprolol and propranolol on hemodynamic effects induced by adrenaline and physical work","volume":"36","author":"Johnsson","year":"1975","journal-title":"Acta Pharmacol Toxicol (Copenh)"},{"key":"10.1016\/j.jaip.2017.12.020_bib18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/AAP.0b013e31829bb9fa","article-title":"Effect of chronic \u03b2-blockade on the utility of an epinephrine-containing test dose to detect intravascular injection in nonsedated patients","volume":"38","author":"Pong","year":"2013","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/j.jaip.2017.12.020_bib19","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1161\/01.RES.69.4.959","article-title":"In\u00a0vivo demonstration of cardiac beta 2-adrenoreceptor sensitization by beta 1-antagonist treatment","volume":"69","author":"Hall","year":"1991","journal-title":"Circ Res"},{"key":"10.1016\/j.jaip.2017.12.020_bib20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1476-5381.1990.tb12715.x","article-title":"Chronic beta 1-adrenoceptor antagonist treatment sensitizes beta 2-adrenoceptors, but desensitizes M2-muscarinic receptors in the human right atrium","volume":"101","author":"Motomura","year":"1990","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jaip.2017.12.020_bib21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.CIR.79.3.483","article-title":"Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy","volume":"79","author":"Heilbrunn","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.jaip.2017.12.020_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajem.2012.11.022","article-title":"Epinephrine-induced myocardial infarction in severe anaphylaxis: is nonselective \u03b2-blockade a contributory factor?","volume":"31","author":"Cunnington","year":"2013","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jaip.2017.12.020_bib23","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0196-0644(89)80324-5","article-title":"Severe epinephrine-propranolol interaction","volume":"18","author":"Gandy","year":"1989","journal-title":"Ann Emerg Med"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219818300059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219818300059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:15:45Z","timestamp":1761974145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219818300059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S2213219818300059"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2017.12.020","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patients Taking \u03b2-Blockers Do Not Require Increased Doses of Epinephrine for Anaphylaxis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2017.12.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}